Bank Of Montreal Immuno Precise Antibodies Ltd. Transaction History
Bank Of Montreal
- $202 Billion
- Q4 2024
A detailed history of Bank Of Montreal transactions in Immuno Precise Antibodies Ltd. stock. As of the latest transaction made, Bank Of Montreal holds 35,307 shares of IPA stock, worth $14,122. This represents 0.0% of its overall portfolio holdings.
Number of Shares
35,307
Previous 57,807
38.92%
Holding current value
$14,122
Previous $36,000
61.11%
% of portfolio
0.0%
Previous 0.0%
Shares
15 transactions
Others Institutions Holding IPA
# of Institutions
20Shares Held
1.91MCall Options Held
0Put Options Held
0-
Ingalls & Snyder LLC New York, NY1.56MShares$624,5320.03% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny78.2KShares$31,2800.0% of portfolio
-
Cibc World Market Inc. Toronto, A641.2KShares$16,4800.0% of portfolio
-
Northern Trust Corp Chicago, IL41.1KShares$16,4420.0% of portfolio
-
Gradient Capital Advisors, LLC26.8KShares$10,7230.0% of portfolio
About ImmunoPrecise Antibodies Ltd.
- Ticker IPA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 24,836,700
- Market Cap $9.93M
- Description
- ImmunoPrecise Antibodies Ltd., together with its subsidiaries, engages in antibody production and provision of related services in the United States, Canada, Europe, Australia, and internationally. The company offers a range of antibodies, enzymes, enzyme activity assays, arthritis animal products, proteins, deiminated proteins, organoid growth ...